News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
274,786 Results
Type
Article (14277)
Company Profile (105)
Press Release (260396)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (88463)
Career Advice (465)
Deals (15434)
Drug Delivery (73)
Drug Development (36798)
Employer Resources (50)
FDA (6409)
Job Trends (6252)
News (151066)
Policy (14177)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (445)
Accelerated approval (13)
Adcomms (8)
Allergies (67)
Alliances (23376)
ALS (56)
Alzheimer's disease (478)
Antibody-drug conjugate (ADC) (99)
Approvals (6601)
Artificial intelligence (202)
Autoimmune disease (39)
Automation (12)
Bankruptcy (150)
Best Places to Work (4386)
BIOSECURE Act (9)
Biosimilars (120)
Biotechnology (40)
Bladder cancer (38)
Brain cancer (30)
Breast cancer (174)
Cancer (1326)
Cardiovascular disease (152)
Career advice (418)
Career pathing (13)
CAR-T (50)
CDC (6)
Cell therapy (151)
Cervical cancer (9)
Clinical research (32096)
Collaboration (728)
Compensation (325)
Complete response letters (33)
COVID-19 (778)
CRISPR (43)
C-suite (435)
Cystic fibrosis (58)
Data (1828)
Denatured (18)
Depression (45)
Diabetes (126)
Diagnostics (1393)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (113)
Drug pricing (114)
Drug shortages (12)
Duchenne muscular dystrophy (80)
Earnings (33566)
Editorial (20)
Employer branding (4)
Employer resources (45)
Events (39134)
Executive appointments (529)
FDA (7513)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (430)
Gene editing (70)
Generative AI (18)
Gene therapy (165)
GLP-1 (440)
Government (1406)
Grass and pollen (4)
Guidances (167)
Healthcare (3592)
HIV (11)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (68)
Immuno-oncology (14)
Indications (53)
Infectious disease (842)
Inflammatory bowel disease (73)
Inflation Reduction Act (7)
Influenza (24)
Intellectual property (113)
Interviews (60)
IPO (5941)
IRA (33)
Job creations (2059)
Job search strategy (374)
JPM (28)
Kidney cancer (9)
Labor market (28)
Layoffs (205)
Leadership (8)
Legal (3456)
Liver cancer (22)
Longevity (8)
Lung cancer (184)
Lymphoma (123)
Machine learning (13)
Management (17)
Manufacturing (413)
MASH (67)
Medical device (1333)
Medtech (1340)
Mergers & acquisitions (9913)
Metabolic disorders (434)
Multiple sclerosis (46)
NASH (14)
Neurodegenerative disease (82)
Neuropsychiatric disorders (37)
Neuroscience (887)
Neurotech (1)
NextGen: Class of 2026 (1590)
Non-profit (604)
Now hiring (17)
Obesity (227)
Opinion (142)
Ovarian cancer (39)
Pain (110)
Pancreatic cancer (51)
Parkinson's disease (80)
Partnered (11)
Patents (221)
Patient recruitment (116)
Peanut (12)
People (29776)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (8319)
Phase 2 (13560)
Phase 3 (12237)
Pipeline (1913)
Policy (135)
Postmarket research (1403)
Preclinical (3344)
Press Release (25)
Prostate cancer (85)
Psychedelics (16)
Radiopharmaceuticals (135)
Rare diseases (353)
Real estate (2663)
Recruiting (18)
Regulatory (10996)
Reports (16)
Research institute (577)
Resumes & cover letters (55)
Rett syndrome (5)
RNA editing (6)
RSV (20)
Schizophrenia (69)
Series A (81)
Series B (49)
Service/supplier (2)
Sickle cell disease (46)
Special edition (10)
Spinal muscular atrophy (81)
Sponsored (9)
Startups (1647)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (68)
The Weekly (45)
Vaccines (231)
Venture capital (32)
Weight loss (140)
Women's health (27)
Worklife (4)
Date
Today (1)
Last 7 days (178)
Last 30 days (723)
Last 365 days (10479)
2026 (959)
2025 (10753)
2024 (12523)
2023 (14303)
2022 (19585)
2021 (20126)
2020 (19086)
2019 (14949)
2018 (11766)
2017 (13914)
2016 (13167)
2015 (15510)
2014 (12457)
2013 (10676)
2012 (11492)
2011 (12011)
2010 (10955)
Location
Africa (318)
Alabama (19)
Alaska (1)
Arizona (78)
Arkansas (3)
Asia (20919)
Australia (2694)
California (3195)
Canada (1481)
China (550)
Colorado (143)
Connecticut (129)
Delaware (123)
Europe (40960)
Florida (601)
Georgia (63)
Hawaii (1)
Idaho (10)
Illinois (348)
India (44)
Indiana (240)
Iowa (2)
Japan (246)
Kansas (77)
Kentucky (20)
Louisiana (4)
Maine (2)
Maryland (442)
Massachusetts (2592)
Michigan (46)
Minnesota (165)
Mississippi (1)
Missouri (33)
Montana (8)
Nebraska (7)
Nevada (16)
New Hampshire (8)
New Jersey (1397)
New Mexico (7)
New York (906)
North Carolina (619)
North Dakota (2)
Northern California (1457)
Ohio (80)
Oklahoma (5)
Oregon (18)
Pennsylvania (716)
Puerto Rico (12)
Rhode Island (17)
South America (509)
South Carolina (10)
Southern California (1389)
Tennessee (53)
Texas (458)
United States (12720)
Utah (59)
Virginia (160)
Washington D.C. (42)
Washington State (224)
West Virginia (1)
Wisconsin (37)
Wyoming (1)
274,786 Results for "infinity pharmaceuticals inc.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform
January 19, 2026
·
3 min read
Press Releases
GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference
September 26, 2025
·
6 min read
Press Releases
Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling
June 18, 2025
·
4 min read
Deals
Infinity Pharmaceuticals Announces Stockholder Approval of Merger with MEI Pharma
Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity”) announced that, based on a preliminary vote count, its stockholders have adopted the previously announced merger agreement providing for the merger with MEI Pharma, Inc. (“MEI”) at the special meeting of Infinity stockholders held earlier today (the “Special Meeting”).
July 14, 2023
·
10 min read
Press Releases
FDA Grants Orphan Drug & Rare Pediatric Disease Designations to Infinant Health for NEC
May 7, 2025
·
2 min read
Deals
Infinity Pharmaceuticals Announces Termination of Merger Agreement with MEI Pharma
Infinity Pharmaceuticals, Inc. announced that it has terminated its previously announced merger agreement providing for the merger with MEI Pharma, Inc. (“MEI”).
July 24, 2023
·
5 min read
Press Releases
Infinity Bio Launches Comprehensive Mouse Antibody Reactome Profiling Service
March 4, 2025
·
2 min read
Deals
MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals
MEI Pharma, Inc. (NASDAQ: MEIP) (the “Company”) today reminded shareholders to vote FOR the Company’s pending transaction with Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity”) in connection with the upcoming special meeting on July 14, 2023.
July 7, 2023
·
11 min read
Press Releases
Agilent Announces My Green Lab Ecolabel 2.0 for the New Infinity III LC Series
May 20, 2025
·
3 min read
Deals
ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.
Infinity Pharmaceuticals, Inc. announced today that leading independent proxy advisor Institutional Shareholder Services Inc. (“ISS”) has recommended that Infinity stockholders vote FOR the merger with MEI Pharma, Inc.
July 5, 2023
·
11 min read
1 of 27,479
Next
